Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,347 | 2 | 94.6% |
| Food and Beverage | $76.59 | 4 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $1,000 | 1 | $0 (2017) |
| Cepheid | $347.00 | 1 | $0 (2020) |
| Insmed, Inc. | $35.59 | 2 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $22.68 | 1 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $18.32 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $347.00 | 1 | Cepheid ($347.00) |
| 2019 | $58.27 | 3 | Insmed, Inc. ($35.59) |
| 2017 | $1,018 | 2 | Philips Electronics North America Corporation ($1,000) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/24/2020 | Cepheid | GENEXPERT (Device) | Consulting Fee | Cash or cash equivalent | $347.00 | General |
| Category: MOLECULAR DIAGNOSTICS | ||||||
| 08/08/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Respiratory | ||||||
| 05/14/2019 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Respiratory | ||||||
| 03/14/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2017 | Philips Electronics North America Corporation | Patient Monitoring U (Device) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/10/2017 | Teva Pharmaceuticals USA, Inc. | GRANIX (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 34 | $6,800 | $2,986 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99183 | Management of oxygen chamber therapy | Facility | 2023 | 16 | 34 | $6,800 | $2,986 | 43.9% |
About Dr. David Ratto, M.D
Dr. David Ratto, M.D is a Pulmonary Disease healthcare provider based in Arcadia, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528035417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Ratto, M.D has received a total of $1,424 in payments from pharmaceutical and medical device companies, with $347.00 received in 2020. These payments were reported across 6 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($1,347).
As a Medicare-enrolled provider, Ratto has provided services to 16 Medicare beneficiaries, totaling 34 services with total Medicare billing of $2,986. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Arcadia, CA
- Active Since 03/01/2006
- Last Updated 07/27/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1528035417
Products in Payments
- Patient Monitoring U (Device) $1,000
- GENEXPERT (Device) $347.00
- Arikayce (Drug) $35.59
- LONHALA MAGNAIR (Drug) $22.68
- GRANIX (Drug) $18.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.